Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zepp Health (ZEPP) EBITDA (2016 - 2025)

Historic EBITDA for Zepp Health (ZEPP) over the last 10 years, with Q3 2025 value amounting to -$884000.0.

  • Zepp Health's EBITDA rose 9294.89% to -$884000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.3 million, marking a year-over-year increase of 899.27%. This contributed to the annual value of -$47.2 million for FY2024, which is 6426.71% down from last year.
  • Zepp Health's EBITDA amounted to -$884000.0 in Q3 2025, which was up 9294.89% from -$6.1 million recorded in Q2 2025.
  • Zepp Health's EBITDA's 5-year high stood at $71.6 million during Q2 2021, with a 5-year trough of -$155.4 million in Q1 2022.
  • Over the past 5 years, Zepp Health's median EBITDA value was -$10.4 million (recorded in 2023), while the average stood at -$28.9 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 66079.06% in 2021, then plummeted by 152779.55% in 2024.
  • Quarter analysis of 5 years shows Zepp Health's EBITDA stood at $10.1 million in 2021, then crashed by 804.86% to -$71.0 million in 2022, then soared by 100.88% to $626000.0 in 2023, then tumbled by 1527.8% to -$8.9 million in 2024, then skyrocketed by 90.11% to -$884000.0 in 2025.
  • Its EBITDA stands at -$884000.0 for Q3 2025, versus -$6.1 million for Q2 2025 and -$18.4 million for Q1 2025.